OTC Pharmaceuticals - Netherlands

  • Netherlands
  • Revenue in the OTC Pharmaceuticals market amounts to €1,018.00m in 2024. The market is expected to grow annually by 3.10% (CAGR 2024-2029).
  • The market's largest segment is the segment Cold & Cough Remedies with a market volume of €216.40m in 2024.
  • In global comparison, most revenue is generated in the United States (€37,850m in 2024).
  • In relation to total population figures, per person revenues of €57.58 are generated in 2024.
  • In the OTC Pharmaceuticals market, 28.2% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The OTC Pharmaceuticals market in Netherlands has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences in the Netherlands have shifted towards self-care and self-medication, driving the demand for OTC pharmaceuticals. Consumers are increasingly seeking convenience and accessibility when it comes to managing their health. They prefer to treat minor ailments and common health issues themselves, rather than visiting a healthcare professional.

This has led to an increased reliance on OTC medications for self-treatment. In line with global trends, the OTC Pharmaceuticals market in Netherlands has seen a rise in demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as more natural and holistic.

This has led to the introduction of a wide range of herbal and natural OTC pharmaceutical products in the market. Another trend in the market is the increasing popularity of online pharmacies and e-commerce platforms. Consumers are now able to purchase OTC pharmaceuticals conveniently from the comfort of their own homes.

This has not only provided greater accessibility to a wider range of products but has also enabled consumers to compare prices and read reviews before making a purchase. In addition to customer preferences, local special circumstances have also played a role in the development of the OTC Pharmaceuticals market in Netherlands. The country has a well-developed healthcare system, with a high level of healthcare literacy among its population.

This has contributed to the growing acceptance and adoption of self-medication practices. Furthermore, the Netherlands has a strong regulatory framework for OTC pharmaceuticals. The government has implemented strict regulations to ensure the safety and efficacy of these products.

This has instilled confidence in consumers and has contributed to the growth of the market. Underlying macroeconomic factors have also influenced the development of the OTC Pharmaceuticals market in Netherlands. The country has a stable economy with high disposable incomes.

This has allowed consumers to spend more on healthcare and wellness products, including OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Netherlands is experiencing growth due to customer preferences for self-care, the rise of natural and herbal remedies, the popularity of online pharmacies, local special circumstances such as a well-developed healthcare system and strong regulatory framework, and underlying macroeconomic factors such as a stable economy and high disposable incomes.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Product Types
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Camille Dubois
Camille Dubois
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)